IFN-γ can also promote tumor growth by affecting the number of vascular endothelial growth inhibitors (VEGIs) (Lu et al., 2014) and the infiltration of immunosuppressive cells (Nishibori et al., 2004). The gene discussed is IFNG; the disease is neoplasm.